Skip to main content
SpringerLink
Log in

The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

In order to establish the role of insulin in the pathogenesis of lipid abnormalities in hyperandrogenic women with the polycystic ovary syndrome (PCO) 49 women aged 18 to 35 yr with a normal glucose tolerance test were studied. They were divided into two groups: 27 women with PCO (9 obese and 18 nonobese), and 22 healthy women (12 with simple obesity and 10 with normal body weight). In the PCO group, the fasting insulin levels and the insulin response to oral glucose load were higher than in the matched controls. Significantly lower levels of HDL2-cholesterol and higher levels of apolipoprotein B were observed in obese and non nonobese PCO patients. In obese women with PCO this was associated with lower levels of HDL-cholesterol and apolipoprotein A-l (Apo A-l), whereas the levels of total triglycerides and VLDL-triglycerides (VLDL-TG) were increased. Multiple regression analysis in PCO women, after adjustment for age, body mass index and the levels of insulin and sex hormones, showed a strong positive correlation between the fasting insulin levels and total triglycerides and VLDL-TG, while a negative correlation was found between fasting insulin levels and apo A-l. These results indicate that hyperinsulinemia may play a role in the development of lipid disturbances in women with the PCO.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Johansson S., Bondjers G., Fager G., Wedel H., Tsipogiani A., Olofsson S., Vedin A., Wikiund O., Wilhelmsson C. Serum lipids and apolipoprotein levels in women with acute myocardial infarction. Arteriosclerosis 8: 742, 1988.

    Article  PubMed  CAS  Google Scholar 

  2. Lapidus L., Bangtsson C., Lindquist O., Sigurdsson J.A., Rybo E. Triglycerides — main lipid risk factor for cardiovascular disease in women? Acta Med. Scand. 217: 481, 1985.

    Article  PubMed  CAS  Google Scholar 

  3. Godsland J.F., Wynn V., Path F.R.C., Crook D., Miller N.E. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am. Heart J. 114: 1467, 1987.

    Article  PubMed  CAS  Google Scholar 

  4. Franks S. Polycystic ovary syndrome: a changing perspective. Clin. Endocrinol. (Oxf.) 31: 87, 1989.

    Article  CAS  Google Scholar 

  5. Smith S., Ravinkar V.A., Barbieri R.L. Androgen and insulin response to an oral glucose challenge in hyperandrogenic women. Fertil. Steril. 48: 72, 1987.

    PubMed  CAS  Google Scholar 

  6. Burghen G.A., Givens J.A., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinemia in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.

    Article  PubMed  CAS  Google Scholar 

  7. Lithell H., Nillius S.J., Bergh T., Selinus J. Metabolic profile in obese women with polycystic ovary syndrome. Int. J. Obes. 11: 1, 1987.

    PubMed  CAS  Google Scholar 

  8. Wild R.A., Painter P.C., Coulson P.B., Carruth K.B., Ranney G.B. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 61: 946, 1985.

    Article  PubMed  CAS  Google Scholar 

  9. Rebuffe-Scrive M., Cullberg G., Lundberg P.A., Lindsted G., Björntorp P. Anthropometric variables and metabolism in polycystic ovarian disease. Horm. Metab. Res 21: 391, 1989.

    Article  PubMed  CAS  Google Scholar 

  10. Mattson L.A., Cullberg G., Hamberger L, Samsioe G., Silferstoipe G. Lipid metabolism in women with polycystic ovary syndrome: Possible implication for an increased risk of coronary heart disease. Fertil. Steril. 42: 579, 1984.

    Google Scholar 

  11. Chang R.J., Nakamura R.M., Judd H.L, Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovary disease. J. Clin. Endocrinol. Metab. 57: 356, 1983.

    Article  PubMed  CAS  Google Scholar 

  12. Barbieri R.L, Smith S., Ryan K.H. The role of hyperinsulienemia in the pathogenesis of ovarian hyperandrogenism. Fertil. Steril. 50: 197, 1988.

    PubMed  CAS  Google Scholar 

  13. Pyöräliä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131, 1979.

    Article  Google Scholar 

  14. Ducimetiere P., Eschwege E., Papoz L., Richard J.L., Claude J.R., Rosselin G. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205, 1980.

    Article  PubMed  CAS  Google Scholar 

  15. Welborn T.A., Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentration. Diabetes Care 2: 156, 1979.

    Article  Google Scholar 

  16. Reaven G.M., Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37: 1595, 1988.

    Article  PubMed  CAS  Google Scholar 

  17. Tobey T.A., Greenfield M., Kraemer F., Reaven G.M. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30: 165, 1981.

    Article  PubMed  CAS  Google Scholar 

  18. Gidez L.J., Miller G.J., Burstein M., Eder H.A. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J. Lipid Res. 23: 1206, 1982.

    PubMed  CAS  Google Scholar 

  19. Grafnetter D., Fodor J., Teply V., Zacek K. The effect of storage on levels of cholesterol in serum as measured by a simple, direct method. Clin. Chim. Acta 16: 33, 1967.

    Article  PubMed  CAS  Google Scholar 

  20. Wahlefeld A.W. Triglyceride determination after enzymatic hydrolysis. In: Bergnayer H.U. (Ed.), Methods in enzymatic analysis. Vol D. Academic Press, New York, 1974, p. 72.

    Google Scholar 

  21. Slowinska-Srzednicka J., Zgliczynski S., Ciswicka-Sznajderman M., Srzednicki M., Soszynski P., Bednarska M., Woroszylska M., Ruzyllo W., Sadowski Z. Decreased plasma dehydroepiandrosterone sulphate and dihydrotestosterone concentrations in young men after myocardial infarction. Atherosclerosis 79: 197, 1989.

    Article  PubMed  CAS  Google Scholar 

  22. Foster D.W. Insulin resistance — a secret killer? N. Engl. J. Med. 320: 733, 1989.

    Article  PubMed  CAS  Google Scholar 

  23. Slowinska-Srzednicka J., Zgliczynski S., Soszynski P., Zgliczynski W., Jeske W. High blood pressure and hyperinsulinemia in acromegaly and obesity. Clin. Exp. Hypertens. All: 407, 1989.

    Article  Google Scholar 

  24. Reaven G.M., Hoffman B.B. A role for insulin in the aetiology and course of hypertension. Lancet 2: 435, 1987.

    Article  PubMed  CAS  Google Scholar 

  25. Nestler J.E., Clore J.N., Blackard W.G. The central role of obesity (hyperinsulinemia) in the pathogenesis of polycystic ovary syndrome. Am. J. Obstet. Gynecol. 161: 1095, 1989.

    Article  PubMed  CAS  Google Scholar 

  26. Poison D.W., Adams J., Wadsworth J., Franks S. Polycystic ovaries — a common finding in normal women. Lancet 1: 870, 1988.

    Google Scholar 

  27. Castelli W.P. The triglyceride issue: A view from Framingham. Am. Heart J. 112: 432, 1986.

    Article  PubMed  CAS  Google Scholar 

  28. Haffner S.M., Katz M.S., Stern M.P., Dunn J.F. The relationship of sex hormones to hyperinsulinemia and hyperglycemia. Metabolism 37: 683, 1988.

    Article  PubMed  CAS  Google Scholar 

  29. Nestler J.E., Barlascini C.O., Matt D.W., Steingold K.A., Plymate S.R., Clore J.N., Blackard W.G. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 68: 1027, 1989.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology, Medical Center for Postgraduate Education, Warsaw, Poland

    J. Slowińska-Srzednicka, S. Zgliczyński, M. Wierzbicki, U. Stopińska-Gluszak, W. Zgliczyński & P. Soszyński

  2. Institute of Cardiology, Warsaw, Poland

    M. Srzednicki, E. Chotkowska, M. Bednarska & Z. Sadowski

  3. Department of Endocrinology, Bielanski Hospital, Ceglowska 80, 01-809, Warsaw, Poland

    J. Slowińska-Srzednicka

Authors
  1. J. Slowińska-Srzednicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Zgliczyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Wierzbicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Srzednicki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. U. Stopińska-Gluszak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Zgliczyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P. Soszyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Chotkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Bednarska
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Z. Sadowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slowińska-Srzednicka, J., Zgliczyński, S., Wierzbicki, M. et al. The role of hyperinsulinemia in the development of lipid disturbances in nonobese and obese women with the polycystic ovary syndrome. J Endocrinol Invest 14, 569–575 (1991). https://doi.org/10.1007/BF03346870

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346870

Key-words

Search

Navigation